|
Post by JHam on Oct 20, 2014 3:59:46 GMT
Just give a quick recap of where we stand with this one for anyone interested. There are five major milestones yet to be released by year's end that should be pps drivers. The CEO guided at the last presentation that the company is still on course to meet all of these milestones. With only 10 weeks left in the year it's got to start to happen soon in a big flurry. Some people are expecting these events to make the pps absolutely skyrocket to above $1.00 and beyond. It did go to $.97 earlier this year when they announced preliminary data, so I wouldn't say it is out of the realm of possibility. My pie in the sky pps by year's end would be $.82 ($200M market cap). My cost average is $.46, so I would be very satisfied with anything above $.65. Here is a refresher of the upcoming milestones:
Phase 1 Melanoma study for long term survival data
Phase 2 Merkel Cell Interim Phase 2 data
Phase 2B Melanoma combination study strategy / initiation
Initiation of new Phase 1 and 2 clinical study in non skin cancer indication (Breast or Head/Neck cancers are probable)
Final Melanoma Phase 2 data and expanded Phase 2 interim
|
|
|
Post by RLC on Nov 3, 2014 16:26:36 GMT
There's a lot of buying pressure out there right now. It would be really nice to see some support above $0.50!
I've accumulated a pretty nice position here over the past few months (w/ a cost basis at $0.45).
|
|
|
Post by lcd on Nov 3, 2014 17:05:17 GMT
Nice average RLC. I didn't buy more on the lows last month until Friday when I added in at .50 which is my average. It will definitely be an interesting one to watch over the next few weeks. Good luck.
|
|
|
Post by JHam on Nov 3, 2014 17:24:38 GMT
There's a lot of buying pressure out there right now. It would be really nice to see some support above $0.50! I've accumulated a pretty nice position here over the past few months (w/ a cost basis at $0.45). Nice. I am not sure what to think. I am not sure if it is up on the news from today (unlikely in my opinion as it just seems to be an agenda calendar of typical conference appearances), or if it is a continuation of the run-up at the last week, which I assumed was due to anticipation of milestones. I wouldn't be surprised to see it head back down into the $.40's if no data results etc...are released in the next few days. Then again, I really don't know. I am comfortable with my position, average at $.46, and will probably hold until the majority of the news comes out. Or until it runs up in anticipation of the news to the point where it is too hard not to sell some.
|
|
|
Post by happyjawa on Nov 3, 2014 18:09:02 GMT
There's a lot of buying pressure out there right now. It would be really nice to see some support above $0.50! I've accumulated a pretty nice position here over the past few months (w/ a cost basis at $0.45). Nice. I am not sure what to think. I am not sure if it is up on the news from today (unlikely in my opinion as it just seems to be an agenda calendar of typical conference appearances), or if it is a continuation of the run-up at the last week, which I assumed was due to anticipation of milestones. I wouldn't be surprised to see it head back down into the $.40's if no data results etc...are released in the next few days. Then again, I really don't know. I am comfortable with my position, average at $.46, and will probably hold until the majority of the news comes out. Or until it runs up in anticipation of the news to the point where it is too hard not to sell some. Last two weeks of the year are Christmas and New Years. I think a lot of people assume November or never for major news if the company is going to hit milestones this year.
|
|
|
Post by JHam on Nov 13, 2014 16:09:07 GMT
I didn't add any more today, but just wanted to mention that this one is really going as planned. Increase in volume and pps day by day as we get closer to December and the new data release (other catalysts). Nice to be up 22% on this one (exactly like NRIFF) before any of the catalysts have come into play (exactly like NRIFF). I am trying to decide if this will be a buy the rumor sell the news type deal.
|
|
|
Post by JHam on Nov 17, 2014 16:01:05 GMT
|
|
|
Post by JHam on Nov 17, 2014 17:21:22 GMT
Based on today's pps action, looks like most aren't too concerned with the Pfizer/Merck deal.
|
|
|
Post by JHam on Nov 18, 2014 4:58:25 GMT
Nice action today again for ONCS. Glad to see a solid rise on high volume (almost 1M shares). I have lost track of how many conferences, both science and corporate, they are presenting at in the next few weeks, but it is a lot. A lot of chances to make those milestone announcements, which is what I think will happen. Stifel is tomorrow.
P.S. It turns out that the Merck/Pfizer deal was with Merck Germany not Merck US. Big difference.
|
|
|
Post by JHam on Nov 18, 2014 5:20:56 GMT
Just to clarify, Stifel is tomorrow meaning Wednesday 11/19 at 4:45pm est. It's already Tuesday afternoon here where I am.
|
|
|
Post by JHam on Jan 2, 2015 17:42:20 GMT
Yep, I said i wouldn't but I added a small chunk today with BCLI profits.
|
|
|
Post by JHam on Jan 6, 2015 13:30:04 GMT
Maybe not even worth mentioning, but around this time last year ONCS announced their milestones for the year. Dhillon has said that they will do the same this year. It may not be much of a pps mover, but I do think it will happen in the next week or two.
|
|
|
Post by RLC on Jan 6, 2015 21:11:48 GMT
I've been adding to my position here quite a bit. ONCS is now my largest position (barely beating ATHX).
Just noticed that it's showing the last trade at 0.562 (up 25%), however the bid/ask (0.4302/0.432) doesn't reflect the market valuing it here. Scratching my head over here... with a smile on face.
Over 30,000 shares just traded above 0.56.....
|
|
|
Post by RLC on Jan 6, 2015 21:20:10 GMT
And a 20,000 share block traded hands at 0.582 at 4:10 pm. I'm not sure if this is a fluke or what the heck is going on. Maybe someone put some market orders in and got taken... ? I'm going to assume we open below $0.45 tomorrow.
|
|
|
Post by lcd on Jan 6, 2015 21:35:24 GMT
Someone in the google group (https://groups.google.com/forum/#!forum/oncs-message-board) mentioned the same thing yesterday and others confirmed it again today. The stock did slip off the OTC yesterday and onto pink sheets but is back on the OTC. Maybe that has something to do with it?
I too added some ONCS yesterday with my BCLI profits. I then went over to the google group and got depressed by all the doom and gloom from investors there who seem to be averaged in at $.60 or more. I now have a large chunk averaged at $.46 so I am going to sit tight and hope for a series of good catalysts in Q1.
|
|
|
Post by JHam on Jan 6, 2015 22:03:06 GMT
Someone in the google group (https://groups.google.com/forum/#!forum/oncs-message-board) mentioned the same thing yesterday and others confirmed it again today. The stock did slip off the OTC yesterday and onto pink sheets but is back on the OTC. Maybe that has something to do with it? I too added some ONCS yesterday with my BCLI profits. I then went over to the google group and got depressed by all the doom and gloom from investors there who seem to be averaged in at $.60 or more. I now have a large chunk averaged at $.46 so I am going to sit tight and hope for a series of good catalysts in Q1. Yeah weird. My TD Ameritrade account is showing that it closed at $.551 and that I am up 20%.
|
|
|
Post by JHam on Jan 6, 2015 22:07:00 GMT
People are freaking out over it on the GG, lol. Maybe this has something to do with it? OTC_Markets OTC Markets Launches New OTCQX® Indices OTC Markets Group recently launched the OTCQX Composite Index (.OTCQX), OTCQX International Index (.OTCQXINT) and OTCQX U.S. Index (.OTCQXUS), to provide investors with a benchmark of the established, global and growth companies traded on the OTCQX marketplace. The new OTCQX indices join the existing OTCM QX ADR 30 Index (.OTCQX30), powered by BNY Mellon Indices. The more than 350 U.S. and global companies traded on the OTCQX® marketplace are distinguished by high financial and disclosure standards and sponsorship by a third party professional advisor. These companies are amongst the largest and most actively traded on our three marketplaces - OTCQX®, OTCQB® and OTC Pink®. A profile of the new OTCQX indices: OTCQX Composite Index – a benchmark to track the overall performance of the OTCQX marketplace. The index is comprised of U.S. and global securities, including ADRs and ordinary shares. Click here to view a full list of constituents. OTCQX International Index – an index comprised of companies with a primary listing on an international stock exchange that have qualified to trade on OTCQX in the U.S. The companies, which represent over 20 countries, range from large cap global companies, such as Danone (OTCQX: DANOY), BASF SE (OTCQX: BASFY), BNP Paribas (OTCQX: BNPQY) and Roche Holding Ltd (OTCQX: RHHBY), to growing international companies, such as Fission Uranium Corp (OTCQX: FCUUF), ProMetic Life Sciences Inc. (OTCQX: PFSCF), and Starpharma Holdings Ltd. (OTCQX: SPHRY). Click here to view a full list of constituents. OTCQX U.S. Index – a benchmark for U.S. companies qualified to trade on OTCQX. The index constituents include U.S. established and growth companies, such as Computer Services (OTCQX: CSVI) and Youngevity International (OTCQX: YGYI), as well as U.S. community banks, such as Isabella Financial (OTCQX: ISBA) and NASB Financial (OTCQX: NASB). Click here to view a full list of constituents. The OTCQX Composite Index, OTCQX International Index and OTCQX U.S. Index are all market capitalized-weighted and have minimum liquidity screens to ensure tradability. Index data is priced in real-time and is available via major worldwide market data vendor networks and other print and electronic information media vendors. Read the full press release on the launch of the OTCQX Indices. Contact Corporate Services to learn more about our indices and the U.S. and global companies traded on the OTCQX marketplace. Corporate Services OTC Markets Group www.otcmarkets.com +1.212.896.4420 issuers@otcmarkets.com
|
|
|
Post by JHam on Jan 6, 2015 22:10:04 GMT
One guy on Yahoo said another stock he owns on the OTC is up over 2,000% even though it closed even. I am sure it is a glitch, but I wonder if people sold into this glitch if they would really capture that appreciation. I doubt it, but curious.
|
|
|
Post by RLC on Jan 6, 2015 22:23:40 GMT
It's fixed
|
|
|
Post by JHam on Jan 6, 2015 22:42:44 GMT
It's fixed Yep. OTC is having some weird glitches the past few days. North Korea?
|
|